BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7601145)

  • 1. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
    Sahl HG; Jack RW; Bierbaum G
    Eur J Biochem; 1995 Jun; 230(3):827-53. PubMed ID: 7601145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique peptide modifications involved in the biosynthesis of lantibiotics.
    Jack RW; Sahl HG
    Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple activities in lantibiotics--models for the design of novel antibiotics?
    Pag U; Sahl HG
    Curr Pharm Des; 2002; 8(9):815-33. PubMed ID: 11945173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
    Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lantibiotic gene clusters and encoded proteins.
    Siezen RJ; Kuipers OP; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):171-84. PubMed ID: 8775977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslationally modified bacteriocins--the lantibiotics.
    Guder A; Wiedemann I; Sahl HG
    Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.
    Sahl HG; Bierbaum G
    Annu Rev Microbiol; 1998; 52():41-79. PubMed ID: 9891793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of lantibiotic biosynthesis.
    Jack R; Bierbaum G; Heidrich C; Sahl HG
    Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lantibiotics: mode of action, biosynthesis and bioengineering.
    Bierbaum G; Sahl HG
    Curr Pharm Biotechnol; 2009 Jan; 10(1):2-18. PubMed ID: 19149587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
    Bierbaum G; Sahl HG
    Zentralbl Bakteriol; 1993 Feb; 278(1):1-22. PubMed ID: 8518504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in lantibiotic biosynthesis and mode of action.
    Patton GC; van der Donk WA
    Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lantibiotics: structure, biosynthesis and mode of action.
    McAuliffe O; Ross RP; Hill C
    FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation.
    Meyer C; Bierbaum G; Heidrich C; Reis M; Süling J; Iglesias-Wind MI; Kempter C; Molitor E; Sahl HG
    Eur J Biochem; 1995 Sep; 232(2):478-89. PubMed ID: 7556197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-translational modifications of lantibiotics.
    Kupke T; Götz F
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):139-50. PubMed ID: 8775974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial lantibiotics: strategies to improve therapeutic potential.
    Cotter PD; Hill C; Ross RP
    Curr Protein Pept Sci; 2005 Feb; 6(1):61-75. PubMed ID: 15638769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lantibiotics and their pre-peptides.
    Nes IF; Tagg JR
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):89-97. PubMed ID: 8775969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides.
    Claesen J; Bibb M
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16297-302. PubMed ID: 20805503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
    Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
    Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics synthesized by posttranslational modification.
    Hansen JN
    Annu Rev Microbiol; 1993; 47():535-64. PubMed ID: 8257108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.